Waheed Akhlaq, Alorainy Mohammad S, Alghasham Abdullah A, Khan Suroor A, Raza Muhammad
Department of Pharmacology and Therapeutics, College of Medicine, Qassim University, Saudi Arabia.
Int J Health Sci (Qassim). 2008 Jan;2(1):39-48.
Pyrimidines are a well known group of compounds reported to have different biological activities. Prompted from the diversity of its wider use and being an integral part of genetic material, an effort was made to synthesize a novel series of amino-pyrimidine derivatives of pharmaceutical interest by condensing the guanidinyl derivative of nalidixic acid with different chalcones.
The structures of all synthesized compounds were established on the basis of IR and 1HNMR spectral studies. All of the new compounds in this series were screened for antimicrobial activity. Gram +ve and Gram -ve strains were used to ascertain the spectrum of activity. ED50 values in the tail flick test were determined and recorded. Analgesic potential of compounds by using tail flick test in SWR male mice have also revealed promising results.
All of the derivatives were effective in Gram -ve test against E. coli. None of the compounds show any inhibition of Gram +ve strain S. aureus. m-Bromo substitution derivative of amino-pyrimidines showed appreciable activity against E. coli, while 2,4 dichloro and p-chloro substitution derivatives also demonstrated improved activity. Compound 4 was most potent. The order of potency for these derivatives was 4>5≥6>1>2>7>3. Parallel to antimicrobial activity, m-bromo substitution derivative showed significant (P<0.01) antinociceptive response in comparison to control, and this effect was comparable to aspirin group. Trimethoxy substitution of benzene ring demonstrated moderate activity, whereas p-bromo substitution essentially had no antinociceptive effects in mice.
Comparing meta- and para- bromo substitutions, there had been significant (P<0.01) difference in the antinociceptive response of both the bromo-substituted derivatives. It was observed that bromo-substitution at meta- position demonstrated comparatively higher potential for its antibacterial as well as antinociceptive properties.
嘧啶是一类众所周知的化合物,据报道具有不同的生物活性。鉴于其广泛用途的多样性以及作为遗传物质的重要组成部分,人们尝试通过将萘啶酸的胍基衍生物与不同的查耳酮缩合来合成一系列具有药学意义的新型氨基嘧啶衍生物。
所有合成化合物的结构均通过红外光谱和1H核磁共振光谱研究确定。对该系列中的所有新化合物进行了抗菌活性筛选。使用革兰氏阳性和革兰氏阴性菌株来确定活性谱。测定并记录了甩尾试验中的半数有效剂量(ED50)值。在瑞士韦伯斯特雄性小鼠中使用甩尾试验对化合物的镇痛潜力进行的研究也取得了有前景的结果。
所有衍生物对革兰氏阴性菌大肠杆菌的测试均有效。没有一种化合物对革兰氏阳性菌金黄色葡萄球菌表现出任何抑制作用。氨基嘧啶的间溴取代衍生物对大肠杆菌表现出明显的活性,而2,4-二氯和对氯取代衍生物也表现出增强的活性。化合物4最有效。这些衍生物的效力顺序为4>5≥6>1>2>7>3。与抗菌活性平行,间溴取代衍生物与对照组相比显示出显著(P<0.01)的抗伤害感受反应,且这种效果与阿司匹林组相当。苯环的三甲氧基取代表现出中等活性,而对溴取代在小鼠中基本没有抗伤害感受作用。
比较间溴和对溴取代,两种溴取代衍生物的抗伤害感受反应存在显著(P<0.01)差异。观察到间位溴取代在抗菌和抗伤害感受特性方面表现出相对较高的潜力。